Mitchell Murray D
Liggins Institute, University of Auckland, and National Research Centre for Growth and Development, Auckland 1001, New Zealand.
Mol Biol Cell. 2006 Jan;17(1):549-53. doi: 10.1091/mbc.e05-08-0818. Epub 2005 Oct 26.
The key molecular regulatory mechanisms that govern and coordinate the molecular alterations that underpin the process of human labor remain incompletely understood although enhanced intrauterine prostaglandin production is known to be requisite. Studies from cancer tissues have indicated that at least one key enzyme of prostaglandin biosynthesis can have its activity severely reduced by increased histone deacetylation and enhanced DNA methylation status. We have advanced the hypothesis that similar regulation may occur in intrauterine tissues during pregnancy to prevent inadvertent activation of this powerful initiating signal by dampening responses to premature activation by agents such as cytokines. Our studies have shown that responsiveness of amnion, a key intrauterine tissue, to interleukin-1beta is abrogated by inhibition of histone deacetylation, whereas PGDH amounts were increased basally. The findings do integrate well with others concerning progesterone (inhibitory) actions such that a decrease in the level of histone acetylation in human gestational tissues near term might herald a coordinated series of events that all result in a positive drive for parturition. Hence, a new level of regulatory action and potential therapeutic targets for pathologies such as preterm labor can flow from these findings.
尽管已知子宫内前列腺素生成增加是必要条件,但控制和协调构成人类分娩过程基础的分子改变的关键分子调节机制仍未完全明了。来自癌症组织的研究表明,前列腺素生物合成的至少一种关键酶的活性可因组蛋白去乙酰化增加和DNA甲基化状态增强而严重降低。我们提出了一个假说,即在怀孕期间,子宫内组织可能会发生类似的调节,通过减弱对细胞因子等因子过早激活的反应,来防止这种强大启动信号的意外激活。我们的研究表明,关键子宫内组织羊膜对白细胞介素-1β的反应性可因组蛋白去乙酰化的抑制而消除,而15-羟基前列腺素脱氢酶(PGDH)的量则在基础水平上增加。这些发现确实与其他有关孕酮(抑制)作用的发现很好地整合在一起,以至于足月时人类妊娠组织中组蛋白乙酰化水平的降低可能预示着一系列协调的事件,所有这些事件都导致对分娩的正向驱动。因此,这些发现可能会带来新的调节作用水平以及早产等病理状况的潜在治疗靶点。